{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:39:24Z","timestamp":1780735164785,"version":"3.54.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsradet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.nmd.2021.11.012","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T21:20:52Z","timestamp":1637961652000},"page":"80-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Novel pathogenic ALG2 mutation causing congenital myasthenic syndrome: A case report"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3063-3741","authenticated-orcid":false,"given":"Christoffer","family":"Ehrstedt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Frykholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9395-7132","authenticated-orcid":false,"given":"David","family":"Beeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2178-9413","authenticated-orcid":false,"given":"Anna Rostedt","family":"Punga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.nmd.2021.11.012_bib0001","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.3233\/JND-150098","article-title":"Congenital myasthenic syndromes with predominant limb girdle weakness","volume":"2","author":"Evangelista","year":"2015","journal-title":"J Neuromuscul Dis"},{"issue":"5","key":"10.1016\/j.nmd.2021.11.012_bib0002","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/WCO.0000000000000736","article-title":"The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategies","volume":"32","author":"Vanhaesebrouck","year":"2019","journal-title":"Curr Opin Neurol"},{"issue":"Pt 3","key":"10.1016\/j.nmd.2021.11.012_bib0003","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/brain\/awt010","article-title":"Congenital myasthenic syndromes due to mutations in ALG2 and ALG14","volume":"136","author":"Cossins","year":"2013","journal-title":"Brain"},{"issue":"24","key":"10.1016\/j.nmd.2021.11.012_bib0004","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1073\/pnas.80.24.7466","article-title":"Yeast mutants deficient in protein glycosylation","volume":"80","author":"Huffaker","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.nmd.2021.11.012_bib0005","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1469-8749.2008.02038.x","article-title":"Neurophysiological strategies for the diagnosis of disorders of the neuromuscular junction in children","volume":"50","author":"Pitt","year":"2008","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2021.11.012_bib0006","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mus.25191","article-title":"Determining jitter values in the very young by use of the e-norms methodology","volume":"55","author":"Pitt","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.11.012_bib0007","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jneuroim.2008.06.026","article-title":"Congenital myasthenic syndromes in childhood: diagnostic and management challenges","volume":"201-202","author":"Kinali","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"25","key":"10.1016\/j.nmd.2021.11.012_bib0008","doi-asserted-by":"crossref","first-page":"22498","DOI":"10.1074\/jbc.M302850200","article-title":"A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis","volume":"278","author":"Thiel","year":"2003","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.nmd.2021.11.012_bib0009","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/hmg\/ddy062","article-title":"The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes","volume":"27","author":"McMacken","year":"2018","journal-title":"Hum Mol Genet"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621007173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621007173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:11:45Z","timestamp":1760775105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896621007173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0960896621007173"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2021.11.012","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel pathogenic ALG2 mutation causing congenital myasthenic syndrome: A case report","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2021.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}